Company: VERA
Filing Date: 2025-05-07
Form Type: 10-Q
Source: 0000950170-25-064733
Chunk: 0

Company: Vera Therapeutics, Inc.
Filing Date: 2025-05-07
Form: 10-Q
Item: Part I, Item 1
Chunk 0
---
VERA THERAPEUTICS, INC. 

Condensed Balance Sheets 

(in thousands, except share amounts) 

     March 31,

     December 31,

     2025

     2024

     (unaudited)

     Assets

     Current assets:

     Cash and cash equivalents
      
     $
     55,090

     $
     92,646

     Marketable securities

     534,744

     548,206

     Prepaid expenses and other assets, current

     16,242

     10,366

     Total current assets

     606,076

     651,218

     Property and equipment, net

     1,062

     960

     Operating lease right-of-use assets

     2,915

     3,372

     Prepaid expenses and other assets, noncurrent

     114

     131

     Total assets
      
     $
     610,167

     $
     655,681

     Liabilities and stockholders’ equity

     Current liabilities:

     Accounts payable
      
     $
     9,262

     $
     7,665

     Operating lease liabilities

     1,191

     1,483

     Accrued expenses and other liabilities, current

     11,441

     16,223

     Total current liabilities

     21,894

     25,371

     Long-term debt

     50,908

     50,687

     Operating lease liabilities, noncurrent

     2,366

     2,468

     Total liabilities

     75,168

     78,526

     Stockholders’ equity

     Preferred stock, $0.001 par value; 10,000,000 authorized   as of March 31, 2025 and December 31, 2024; no shares issued   and outstanding as of March 31, 2025 and December 31, 2024

     —

     —

     Class A common stock, $0.001 par value; 500,000,000 shares  authorized as of March 31, 2025 and December 31, 2024;  63,774,158 and 63,559,858 shares issued and outstanding as of  March 31, 2025 and December